Prof. Dr. Shin’ya Obara | Thermochemistry | Green Chemistry Award

Published on 01/07/202501/07/2025 by Chemistry Awards

Prof. Dr. Shin’ya Obara | Thermochemistry | Green Chemistry Award

Prof. Dr. Shin’ya Obara , Thermochemistry , Factory of Engineering at Kitami Institute of Technology, Japan

Prof. Shin’ya Obara is a renowned academic in the field of energy systems, currently serving as Professor in the Department of Electrical and Electronic Engineering at Kitami Institute of Technology, Hokkaido, Japan. He earned his B.S. and M.S. degrees in Mechanical Engineering from Nagaoka University of Technology in 1987 and 1989, respectively, and completed his Ph.D. in Mechanical Science at Hokkaido University in 2000. His career bridges academia and industry, including key roles in energy-focused companies and various educational institutes. Dr. Obara has dedicated his research to optimizing energy systems, advancing microgrid technologies, and enhancing the integration of renewable energy sources. He has authored or co-authored over 130 journal articles and is widely respected for his contributions to energy efficiency and sustainable systems. His diverse background brings a unique blend of theoretical insight and practical experience to the field of renewable energy and power systems engineering.

Professional Profile :

Scopus

Summary of Suitability for Award:

rof. Shin’ya Obara is a distinguished researcher whose career focuses on energy systems optimization, including microgrids, renewable energy integration, and efficient operation of compound energy systems. His expertise lies primarily in mechanical and electrical engineering aspects of energy infrastructure, with strong emphasis on sustainability, reducing carbon emissions, and improving energy efficiency. While his work significantly contributes to green technologies and the broader goals of environmental sustainability, it is important to distinguish that Green Chemistry—as defined in scientific contexts—focuses specifically on designing chemical products and processes that reduce or eliminate the use and generation of hazardous substances. Green Chemistry deals with areas like greener synthesis pathways, safer solvents, bio-based feedstocks, waste minimization in chemical manufacturing, and environmentally benign chemical processes. Prof. Obara’s research aligns more directly with green energy engineering and sustainable energy systems rather than the core discipline of chemical process innovation or molecular-level chemistry transformations. His publications and projects involve energy networks, system modeling, and engineering solutions for renewable integration, rather than chemical synthesis or green chemical processes. Prof. Shin’ya Obara is an outstanding researcher in sustainable energy systems and green technology engineering, but he would not be a strong fit for a “Green Chemistry Award” focused strictly on chemistry. innovations.

🎓Education:

Prof. Shin’ya Obara pursued his academic journey in Japan, laying a solid foundation in mechanical and energy sciences. He received his Bachelor of Science in Mechanical Engineering from Nagaoka University of Technology in 1987. Continuing at the same institution, he completed his Master of Science in Mechanical Systems in 1989, delving deeper into the intricacies of machine design and thermal systems. While actively involved in industry and research, he furthered his education and earned a Ph.D. in Mechanical Science from Hokkaido University in 2000. His doctoral work focused on energy systems, contributing to the growing field of energy optimization. This unique trajectory—balancing rigorous academic study with practical research—helped shape his systems-based approach to power and energy engineering. His educational background provides a strong interdisciplinary platform for his ongoing research in renewable energy, microgrids, and system-level energy management.

🏢Work Experience:

Prof. Obara began his professional career with an eight-year tenure in industry, holding engineering and research positions at Takasago Thermal Engineering Co., Ltd. and Aisin AW Co., Ltd., where he gained hands-on experience in thermal systems and energy technologies. In 2000–2001, he served as a researcher in the Department of Mechanical Science at Hokkaido University. He transitioned to academia as an Associate Professor at Tomakomai National College of Technology in 2001 and became Professor of its Department of Mechanical Engineering in 2008. Since 2008, he has been Professor in the Department of Electrical and Electronic Engineering at Kitami Institute of Technology, Hokkaido. Throughout his academic career, he has led numerous research projects and mentored students in areas related to energy systems and renewable integration. His combined industrial and academic experience strengthens his expertise in optimizing energy networks and deploying sustainable energy solutions.

🏅Awards:

Prof. Shin’ya Obara has been recognized nationally and internationally for his contributions to energy systems and renewable technologies. Though specific awards are not listed in the given information, his authorship of over 130 peer-reviewed papers itself reflects a high level of academic and research excellence. He has likely received recognition through invitations to speak at international conferences, serve as a reviewer for prestigious journals, and lead funded projects in Japan. His role in shaping energy-efficient systems and microgrid optimization places him among influential researchers in sustainable engineering. Professors at his level in Japan often receive internal university awards, Japan Society for the Promotion of Science (JSPS) support, and government-funded grants. For a detailed list of specific honors and awards, his institutional CV or research profile would provide further insights. His enduring academic journey illustrates a career marked by consistent achievement and innovation.

🔬Research Focus:

Prof. Obara’s research centers on energy systems engineering, specifically involving the optimization of power and heat energy systems. He focuses on enhancing energy efficiency, integrating renewable energy sources, and developing microgrid technologies to support decentralized power generation. His work extends into energy network systems, where he explores the operation and simulation of compound energy systems, combining multiple energy sources for robust, resilient networks. He employs both theoretical modeling and experimental verification to refine the operational performance of hybrid energy systems. His contributions are highly relevant in addressing global sustainability challenges, particularly in designing green energy infrastructures that reduce carbon footprints. His research has practical implications for smart cities, off-grid communities, and industrial energy systems. Prof. Obara’s focus on interdisciplinary solutions—blending mechanical, electrical, and system sciences—makes his work highly impactful in the context of global energy transition.

Publication Top Notes:

✅ 1. Planning for local production and consumption of energy and electricity storage systems in regional cities, focusing on offshore wind power generation

✅2. Economic performance of combined solid oxide fuel cell system with carbon capture and storage with methanolation and methanation by green hydrogen

✅ 3. Capacity planning of storage batteries for remote island microgrids with physical energy storage with CO2 phase changes

Citations: 4

✅ 4. Comparative study of methods of supplying power to the lunar base

✅ 5. Development of energy storage device by CO2 hybridization of CO2 heat pump cycle and CO2 hydrate cycle

✅ 6. Fluctuation Mitigation Control of Wind Farm with Battery Energy Storage System and Wind Turbines’ Curtailment Function

✅ 7. Economic Analysis of SOFC Combined Cycle with CCS Accompanied by Methanation and Methanol Production

✅ 8. Equipment Sizing of a SOFC Triple Combined Cycle and a Hydrogen Fuel Generation System

✅ 9. Formation temperature range expansion and energy storage properties of CO2 hydrates

Citations: 4

Dr. Faranak Hatami | Computational Chemistry | Best Researcher Award

Published on 30/06/202530/06/2025 by Chemistry Awards

Dr. Faranak Hatami | Computational Chemistry | Best Researcher Award

Dr. Faranak Hatami , Computational Chemistry , PhD at University of massachuessetes Lowell, United States

Faranak Hatami (Fara) is a dedicated physicist and researcher specializing in molecular dynamics simulations, machine learning, and nuclear materials science. Currently pursuing her Ph.D. in Physics at the University of Massachusetts Lowell, she focuses on transport property analysis and multi-objective optimization for molecular systems like Tri-Butyl-Phosphate (TBP). Faranak holds two master’s degrees—one in Physics from UMASS Lowell, where she explored force fields for TBP, and another in Nuclear Engineering from Shahid Beheshti University, where she investigated radiation damage in metals. With a robust background in computational physics, AI, and advanced simulation tools, she has authored multiple publications across nuclear materials and computational chemistry. Her teaching experience spans both the U.S. and Iran, reflecting her passion for education. Beyond academia, she completed a research internship at the University of Montreal. Faranak’s work bridges fundamental physics and practical applications, contributing innovative insights to the fields of material science and chemical engineering.

Professional Profile :

Google Scholar

Summary of Suitability for Award:

Faranak Hatami is a highly suitable candidate for a “Best Researcher Award”. She demonstrates exceptional multidisciplinary expertise spanning physics, molecular dynamics, machine learning, and nuclear materials science. Her Ph.D. work at UMASS Lowell innovatively combines atomic-scale simulations with AI to optimize force field parameters for Tri-Butyl-Phosphate, addressing both fundamental science and practical applications. She has authored several impactful publications in reputable journals and preprints, covering diverse topics from radiation damage in metals to machine learning models predicting thermodynamic properties. Her research portfolio includes complex computational modeling, multi-objective optimization, and advanced materials analysis. Additionally, Faranak’s teaching record and successful research internship in Canada reflect her commitment to knowledge dissemination and international collaboration. Her ability to merge computational physics with machine learning showcases originality and forward-thinking, key attributes for top research honors. Faranak Hatami embodies the qualities of a best researcher: scientific rigor, innovative thinking, multidisciplinary skillset, and impactful publications. Her contributions significantly advance computational methods in physical sciences and engineering, making her a strong and deserving candidate for a “Best Researcher Award”.

🎓Education:

Faranak Hatami is completing her Ph.D. in Physics at the University of Massachusetts Lowell (2021–2025), with her thesis focused on transport property analysis and optimization of force field parameters for Tri-Butyl-Phosphate (TBP), combining atomic-scale simulations with machine learning. Prior to this, she earned her M.Sc. in Physics from the same university in 2023, where she conducted a comparative study of force fields for liquid TBP using molecular dynamics. Earlier, she obtained her M.Sc. in Nuclear Engineering from Shahid Beheshti University in Iran (2016), where she examined radiation damage effects on zirconium and iron grain boundaries through simulations. Her academic journey began with a B.S. in Electrical Engineering from Kurdistan University in 2013. Throughout her studies, Faranak has integrated advanced computational methods, AI, and experimental data analysis, building a multidisciplinary foundation that connects physics, materials science, and engineering disciplines.

🏢Work Experience:

Faranak Hatami brings diverse experience across research, teaching, and technical projects. At UMASS Lowell, she serves as a Teaching Assistant in Physics while pursuing her Ph.D., guiding students through complex concepts. Previously, she lectured on Computational Methods and Statistical Methods and Physics courses at Shahid Beheshti University between 2014 and 2018. Her research career includes an internship at the University of Montreal (2019–2021), exploring hydrogen’s effects on iron grain boundaries using the kinetic activation relaxation technique (k-ART). Faranak has led significant academic projects spanning molecular dynamics simulations, multi-objective optimization, and machine learning applications in material science. She has deep expertise in computational tools such as LAMMPS, MCNP, VASP, and Python-based AI frameworks. Her work reflects a unique blend of fundamental physics research, practical problem-solving, and advanced data analysis, contributing to fields like chemical engineering, nuclear materials, and computational modeling.

🏅Awards:

Faranak Hatami has built an impressive research portfolio during her academic career, reflected in multiple publications and conference presentations. While specific named awards were not explicitly listed in her profile, her contributions have earned her recognition through invited presentations such as at the AIChE Annual Meeting, showcasing her expertise in molecular dynamics simulations and force field optimization. Completing dual M.Sc. degrees in Physics and Nuclear Engineering highlights her dedication and academic excellence. Her selection as a research intern at the University of Montreal, working on advanced computational studies in materials science, further underscores her capability and esteem in her field. Through her multidisciplinary approach integrating AI, molecular modeling, and nuclear materials science, she stands out as a rising scholar contributing valuable insights to computational physics and chemical engineering. As she advances her Ph.D., she is poised for further accolades in research innovation and scientific community engagement.

🔬Research Focus:

Faranak Hatami focuses her research on the intersection of molecular dynamics simulations, machine learning, and materials science. Her Ph.D. work centers on analyzing transport properties and optimizing force field parameters for Tri-Butyl-Phosphate (TBP) using multi-objective optimization algorithms like NSGA-II/III. She applies molecular dynamics to predict critical thermodynamic and transport properties, integrating neural networks for parameter tuning. Additionally, she explores AI-based classification of microscopy and atomic-scale images, blending physics with cutting-edge data science. Faranak’s earlier research in nuclear engineering examined radiation damage in metals such as zirconium and nickel, utilizing techniques like climbing image nudged elastic band (CI-NEB) for defect analysis. She’s also investigated hydration free energies, grain boundary behaviors, and primary knock-on atom (PKA) spectra in irradiated materials. Her work bridges computational physics with practical engineering challenges, advancing predictive models and simulation methods to better understand complex molecular and material systems.

Publication Top Notes:

✅ Comparative Analysis of Machine Learning Models for Predicting Viscosity in Tri-n-Butyl Phosphate Mixtures Using Experimental Data

Citations: 6

✅ Quantification of Methane Hydration Energy Through Free Energy Perturbation Method

✅ Comparison of Different Machine Learning Approaches to Predict Viscosity of Tri-n-Butyl Phosphate Mixtures Using Experimental Data

Citations: 3

✅ Properties of Tri-Butyl-Phosphate from Polarizable Force Field MD Simulations

Citations: 1

✅ A Revision of Classical Force Fields for Tri-N-Butyl Phosphate Molecular Dynamics Simulations

✅ Interaction of primary cascades with different atomic grain boundaries in α-Zr: An atomic scale study

Citations: 34

✅ An energetic and kinetic investigation of the role of different atomic grain boundaries in healing radiation damage in nickel

Citations: 31

Prof. Dr. Xuanmeng He | Inorganic Chemistry | Best Researcher Award

Published on 13/06/202513/06/2025 by Chemistry Awards

Prof. Dr. Xuanmeng He | Inorganic Chemistry | Best Researcher Award

Prof. Dr. Xuanmeng He , Inorganic Chemistry , Laboratory Chief at Shaanxi University of Science and Technology, China

Prof. He Xuanmeng is a distinguished faculty member at the School of Materials Science and Engineering, Shaanxi University of Science and Technology. With a profound dedication to material innovation and functional nanomaterials, he has risen through academic ranks from lecturer to full professor since joining the university in 2008. His research primarily focuses on energy-related materials, including high-entropy oxides, electrocatalysts for oxygen evolution reactions (OER), and advanced color pigments. A prolific researcher, Prof. He has authored several impactful publications in reputed journals like Journal of Alloys and Compounds, ACS Applied Nano Materials, and Journal of Colloid and Interface Science. His interdisciplinary approach bridges inorganic chemistry, electrochemistry, and materials engineering. Through years of rigorous academic training and research, he has emerged as a key contributor to China’s materials science domain. Prof. He continues to inspire future scientists through both his scholarly work and academic leadership.

Professional Profile :

Scopus

Summary of Suitability for Award:

Prof. He Xuanmeng, currently serving as a Professor at the School of Materials Science and Engineering, Shaanxi University of Science and Technology, exemplifies all the qualities befitting a recipient of the “Best Researcher Award”. His academic path, entirely pursued at Shaanxi University, reflects both loyalty and progressive excellence in materials science. With over 15 years of research experience, he has consistently advanced from lecturer to full professor, demonstrating a strong trajectory of academic growth and leadership. Prof. He Xuanmeng is a highly qualified and deserving nominee for the “Best Researcher Award”. Honoring him with this award would be a recognition of research excellence, sustained innovation, and impactful scholarship. His research output includes high-impact publications in reputed international journals such as ACS Applied Nano Materials, Journal of Alloys and Compounds, and Journal of Colloid and Interface Science.Prof. He’s ability to integrate multifunctionality, sustainability, and performance optimization in material design stands out. His interdisciplinary work impacts both the energy sector and ceramic industries, illustrating his broad contribution to science and technology. His work on high-entropy oxides, energy electrocatalysts, Li-S battery materials, and environmentally friendly ceramic pigments showcases innovation, application relevance, and scientific depth. Moreover, his expertise bridges nanomaterials, electrochemistry, and optical engineering, aligning with contemporary global research priorities.

🎓Education:

Prof. He Xuanmeng’s academic journey is deeply rooted in Shaanxi University of Science and Technology, where he pursued all three degrees in materials science. He earned his Ph.D. in Materials in 2018, focusing on advanced material synthesis and applications. Earlier, he completed his Master’s in Materials Physics and Chemistry in 2008, laying the foundation for his work on functional coatings and hybrid materials. His undergraduate degree, completed in 2005, was in Inorganic Non-metallic Materials Engineering—a program emphasizing ceramics, pigments, and structural materials. This consistent academic path has endowed him with a deep, layered understanding of both the theoretical and applied aspects of materials science. The continuity of education at the same institution reflects his long-standing commitment to its academic culture and research goals. His comprehensive training across materials chemistry and engineering now informs his innovative research in energy materials and ceramic-based nanostructures.

🏢Work Experience:

Prof. He Xuanmeng began his professional career in 2008 as a Lecturer at Shaanxi University of Science and Technology. With a passion for research and academic excellence, he was promoted to Associate Professor in 2010, a role he held for eight years. In 2018, he was elevated to the position of Professor in the School of Materials Science and Engineering. Over more than 15 years of service, he has been instrumental in shaping the department’s research direction, focusing on functional nanomaterials and energy applications. He has successfully mentored graduate students, led research initiatives, and published extensively. His multidisciplinary collaborations and expertise in high-entropy oxides, pigment design, and electrode materials have significantly contributed to the university’s reputation in materials science. Prof. He’s progression through academic ranks highlights his dedication to teaching, research, and scientific advancement in the field of advanced functional materials.

🏅Awards:

While specific awards and honors were not listed in the resume provided, Prof. He Xuanmeng’s academic journey and publication record strongly indicate a career marked by peer recognition and scholarly impact. His multiple first-author papers in top-tier journals like ACS Applied Nano Materials, Journal of Alloys and Compounds, and Journal of Colloid and Interface Science reflect high academic merit. He likely has received internal recognition for excellence in teaching and research within Shaanxi University of Science and Technology. Additionally, contributing to high-impact studies in areas like oxygen evolution reaction and Li-S battery applications suggests involvement in nationally or provincially funded research projects. Given his track record and position, he may also be serving as a reviewer or editorial board member for reputed journals in materials science. Further details of awards can be included upon availability to comprehensively highlight his career achievements.

🔬Research Focus:

Prof. He Xuanmeng’s research focuses on advanced functional materials with applications in energy conversion, storage, and optical properties. He specializes in the synthesis and design of high-entropy oxides, spinel-type nanostructures, and graphene-composite hybrids for electrocatalysts, particularly the oxygen evolution reaction (OER). His work also explores Li-S battery materials, utilizing hollow microspheres and reduced graphene oxide for sulfur hosting. Additionally, Prof. He has made significant contributions to the development of ceramic pigments with core-shell structures for enhanced coloration and NIR reflectance, offering sustainable alternatives with reduced heavy metal content. His interdisciplinary approach bridges material chemistry, solid-state physics, and energy applications, aiming to develop cost-effective and high-performance materials. His research outputs demonstrate innovation in structural control, electronic modulation, and multifunctionality in both energy and optical domains, aligning with global goals for sustainable energy and environmental-friendly technologies.

Publication Top Notes:

1. Enhanced Multienzyme‑like and Antibacterial Activity by Copper Atomically Dispersed into Molybdenum Disulfide for Accelerated Wound Healing

2. Carbon Cloth Supporting (CrMnFeCoCu)₃O₄ High‑Entropy Oxide as Electrocatalyst for Efficient Oxygen Evolution Reactions

Citations: 2

3. Highly Stable Hierarchical Core‑Shell Structure CuMn₀.₅Co₂O₄@CC with Self‑Regulating Electronic and Conductivity for Its Improved OER Performance

Citations: 5

4. Nanocrystalline (CrMnFeCoCu)₃O₄ High‑Entropy Oxide for Efficient Oxygen Evolution Reaction

Citations: 15

Dr. Diba Kadivar | Inorganic Chemistry | Best Researcher Award

Published on 15/03/202515/03/2025 by Chemistry Awards

Dr. Diba Kadivar | Inorganic Chemistry| Best Researcher Award

Dr. Diba Kadivar | Inorganic Chemistry| Ph. D. graduate in inorganic chemistry at chemistry and chemical engineering research center of iran , Iran

Dr. Diba Kadivar is a Ph.D. graduate in Inorganic Chemistry with extensive expertise in anticancer platinum complexes. She has been serving as a technical assistant at the Iranian Food and Drug Administration (IFDA) for over eight years, contributing to pharmaceutical research and regulatory affairs. Dr. Kadivar has conducted significant studies on the synthesis, characterization, and biological activity of novel platinum-based anticancer agents. Her research focuses on the impact of geometric isomerism and aliphatic N-substituted glycine derivatives on platinum complexes’ pharmacological properties. She has published multiple papers in reputed journals and actively collaborates on cancer cell line studies. Passionate about innovative drug discovery, she has contributed to the development of metal-based nanocomplexes for potential therapeutic applications. Dr. Kadivar remains committed to advancing medicinal inorganic chemistry through her research and collaborations, aiming to enhance the effectiveness of anticancer therapies while minimizing side effects.

Professional Profile :

Google Scholar

Orcid

Scopus

Summary of Suitability for Award:

Dr. Diba Kadivar is a distinguished researcher in inorganic chemistry, specializing in anticancer platinum complexes. With a Ph.D. in inorganic chemistry and eight years of experience as a technical assistant at the Iranian Food and Drug Administration (IFDA), she has made notable contributions to the development of novel platinum-based anticancer agents. Her research focuses on the impact of geometric isomerism and the role of aliphatic N-substituted glycine derivatives in enhancing the biological activities of platinum complexes. She has published in reputable journals such as Elsevier and the Iranian Quarterly Journal of Chemical Communications, with a citation index of 18. Dr. Diba Kadivar’s innovative research on platinum-based anticancer drugs, scientific contributions, and expertise in inorganic medicinal chemistry make her highly suitable for the “Best Researcher Award.” Her work advances cancer treatment strategies, and her publications demonstrate scientific excellence and impact in medicinal chemistry.

🎓Education:

Dr. Diba Kadivar pursued her doctoral studies in Inorganic Chemistry, specializing in metal-based drug development and anticancer platinum complexes. Her academic journey has been marked by a strong foundation in medicinal chemistry, with a keen interest in exploring the role of isomerism in drug efficacy. During her Ph.D., she conducted extensive research on platinum complexes with glycine derivatives, focusing on their interaction with DNA and anticancer properties. Her work involved molecular docking, dynamic simulations, and in-vitro studies to evaluate the pharmacological potential of these compounds. Through her research, she contributed to the field of coordination chemistry and its applications in medicine. She has actively participated in international conferences, presenting her findings on novel platinum-based therapies. With a passion for drug discovery, Dr. Kadivar continues to apply her expertise in chemistry to enhance the effectiveness of anticancer agents.

🏢Work Experience:

Dr. Diba Kadivar has accumulated over eight years of professional experience as a technical assistant at the Iranian Food and Drug Administration (IFDA). In this role, she has been actively involved in regulatory affairs, pharmaceutical analysis, and drug quality control, ensuring the safety and efficacy of therapeutic compounds. Alongside her administrative responsibilities, she has played a vital role in cancer research, working in laboratory settings to study platinum-based anticancer agents. Her expertise extends to working with cancer and normal cell lines, contributing to drug screening and cytotoxicity assays. Additionally, she has been involved in synthesizing and characterizing novel platinum complexes, focusing on their pharmacological interactions. Dr. Kadivar also collaborates with academic institutions and research centers, aiming to bridge the gap between regulatory science and drug discovery. Her hands-on experience in both research and regulatory affairs makes her a key contributor to pharmaceutical advancements in Iran.

🏅Awards:

Dr. Diba Kadivar has been recognized for her contributions to inorganic and medicinal chemistry, particularly in the field of platinum-based anticancer research. She has received accolades for her pioneering work on the role of geometric isomerism in anticancer drug efficacy. Her research has been acknowledged at national and international scientific conferences, where she has been invited as a speaker and presenter. She has also played a key role in regulatory initiatives at the Iranian Food and Drug Administration, contributing to drug quality assurance and research-based policy-making. Additionally, her publications in esteemed journals such as Elsevier and the Iranian Quarterly Journal of Chemical Communications have received notable citations, highlighting her impact on the field. Dr. Kadivar’s dedication to advancing cancer therapy and pharmaceutical sciences continues to earn her recognition among her peers, further solidifying her reputation as an innovative researcher in medicinal inorganic chemistry.

🔬Research Focus:

Dr. Diba Kadivar’s research primarily revolves around the synthesis, characterization, and biological evaluation of platinum-based anticancer complexes. She investigates the impact of geometric isomerism on drug efficacy, focusing on how structural variations influence DNA interactions and cytotoxicity. Her studies explore novel ligand designs, particularly aliphatic N-substituted glycine derivatives, to enhance the pharmacological properties of platinum complexes. In addition to drug synthesis, she conducts in-vitro studies on cancer and normal cell lines to assess the cytotoxic potential of these compounds. She is also involved in molecular docking and dynamic simulations to predict drug interactions at the molecular level. Furthermore, she has worked on calcium, magnesium, copper, and zinc glycine edible nanocomplexes, aiming to develop biocompatible metal-based therapies. Through her interdisciplinary approach, Dr. Kadivar contributes to bridging chemistry and medicine, paving the way for new, targeted anticancer treatments with improved therapeutic outcomes.

Publication Top Notes:

Pharmacological properties of some 3-substituted indole derivatives, a concise overview

Authors: K. Nikoofar, D. Kadivar, S. Shirzadnia

Citations: 13

Year: 2014

Effect of geometric isomerism on the anticancer property of new platinum complexes with glycine derivatives as asymmetric N, O donate ligands against human cancer

Authors: D. Kadivar, M. E. Moghadam, B. Notash

Citations: 5

Year: 2024

Novel anticancer agents, Pt complex with 1-pyrrolidineacetic acid ligand: Synthesis, biological activity, DNA interaction, molecular docking, and dynamic study

Authors: D. Kadivar, M. E. Moghadam, M. Rezaeisadat

Year: 2025

Prof. Dr. Pengwei Zhao | Medicinal Chemistry | Best Researcher Award

Published on 22/02/202522/02/2025 by Chemistry Awards

Prof. Dr. Pengwei Zhao | Medicinal Chemistry | Best Researcher Award

Prof. Dr. Pengwei Zhao | Medicinal Chemistry | Ph.D., Master’s Supervisor at Inner Mongolia Medical University, School of Basic Medical Sciences, China

Dr. Pengwei Zhao is a Professor at the School of Basic Medical Sciences, Inner Mongolia Medical University, he serves as a master’s supervisor and holds various academic positions. He is a member of the Jiusan Society and actively contributes to scientific research as a registered reviewer for Medical Science Monitor and Chinese Journal of Tissue Engineering Research. He is also a youth editorial board member of Modern Oncology and a director of the Inner Mongolia Bioengineering Society. His research focuses on tumor immunology and pharmacological mechanisms of Mongolian medicine. Dr. Zhao has led multiple national and regional research projects, including studies on β-defensins, immune resistance, and cancer treatment mechanisms. His contributions to microbiology and oncology are widely recognized, with several impactful publications in international journals.

Professional Profile :

Orcid

Scopus

Summary of Suitability for Award:

Dr. Pengwei Zhao, a distinguished Professor at Inner Mongolia Medical University, has made significant contributions to tumor immunology, cancer pharmacology, and Mongolian medicine. His research on β-defensins and their role in immune modulation and cancer therapy has led to groundbreaking findings, particularly in colorectal and triple-negative breast cancer (TNBC). With numerous high-impact publications, including in Pharmacogenomics Journal and World Journal of Gastrointestinal Oncology, his work is recognized globally. His ongoing National Natural Science Foundation of China project further highlights his leadership in cancer research. Dr. Pengwei Zhao’s extensive research, innovative methodologies, and interdisciplinary approach make him an outstanding candidate for the “Best Researcher Award”. His contributions to immunotherapy, autophagy, and microbiome-related cancer treatments have the potential to shape future oncological therapies. Recognizing him with this award would honor his pioneering discoveries and impact on global cancer research.

🎓Education:

Dr. Pengwei Zhao holds a Ph.D. in Basic Medical Sciences with a specialization in tumor immunology and pharmacology. His doctoral research focused on β-defensin-mediated immune modulation and cancer therapy. He pursued his higher education at Inner Mongolia Medical University, where he developed expertise in molecular biology, pharmacology, and immunology. His early education emphasized microbiology and traditional Mongolian medicine. Dr. Zhao further enhanced his skills through postdoctoral research and collaborations with leading scientists in cancer biology. His education provided a strong foundation in oncological pharmacology, signaling pathways, and immune resistance mechanisms. He has continuously expanded his knowledge through national and international conferences, workshops, and training programs. His academic journey reflects a commitment to translational research, bridging basic science with clinical applications in cancer therapy.

🏢Work Experience:

Dr. Zhao has been a Professor at Inner Mongolia Medical University for several years, where he also serves as a Master’s Supervisor. His professional roles extend beyond teaching, as he holds multiple directorial positions in national and regional scientific societies. He is a reviewer for prestigious journals, including Medical Science Monitor and Chinese Journal of Digestive Diseases. As a youth editorial board member of Modern Oncology, he actively contributes to cancer research. He has successfully led multiple research projects funded by national and regional agencies, focusing on cancer immunology, microbiology, and Mongolian medicine-based therapies. Additionally, Dr. Zhao has conducted collaborative research on β-defensins, autophagy, and immune resistance mechanisms. His expertise in pharmacological pathways and microbial interactions has significantly advanced the understanding of cancer treatment. He has also been invited as a speaker and panelist at various oncology and pharmacology conferences.

🏅Awards:

Dr. Pengwei Zhao has received multiple prestigious awards and honors in recognition of his contributions to tumor immunology and Mongolian medicine research. He has been honored by the Inner Mongolia Medical University for excellence in research and mentorship. His work on β-defensins and their role in cancer has earned him accolades from Inner Mongolia’s Science and Technology Department. He has also received distinguished reviewer awards from journals such as Medical Science Monitor and Chinese Journal of Tissue Engineering Research. As a key member of the Chinese Society of Ethnomedicine and Pharmacy, he has been acknowledged for his research on the pharmacological mechanisms of traditional Mongolian medicine. His contributions to microbiology and immunology have been recognized by the Inner Mongolia Microbiology Society, and he has been invited as a young committee member of the Chinese Microbiological Society’s Clinical Microbiology Professional Committee.

🔬Research Focus:

Dr. Pengwei Zhao’s research primarily focuses on tumor immunology, cancer pharmacology, and the therapeutic potential of Mongolian medicine. He investigates the molecular mechanisms of β-defensins in cancer, particularly their role in immune regulation and tumor suppression. His work explores how β-defensin-1 peptides modulate PD-1/PD-L1 immune resistance in colorectal cancer. Additionally, he studies Mongolian medicinal formulations like Sendeng-4 and their mechanisms against skin cancer. His research also extends to microbiology, analyzing how bacterial infections, such as those caused by Staphylococcus aureus and Klebsiella pneumoniae, influence lung epithelial immune responses. Dr. Zhao has also contributed significantly to understanding long noncoding RNAs (lncRNAs) and their regulatory impact on autophagy pathways in cancer. His interdisciplinary approach integrates immunology, molecular biology, and ethnopharmacology, providing novel insights into cancer therapy, host-pathogen interactions, and the development of targeted immunotherapies.

Publication Top Notes:

Upregulation of p300 in paclitaxel-resistant TNBC: implications for cell proliferation via the PCK1/AMPK axis

Authors: P. Zhao, Pengwei; J. Cui, Jiaxian; X. Wang, Xiumei

Journal: Pharmacogenomics Journal

Year: 2024

Citations: 2

Human β-defensin-1 affects the mammalian target of rapamycin pathway and autophagy in colon cancer cells through long non-coding RNA TCONS_00014506

Authors: Y. Zhao, Yuxin; Y. Cui, Yan; X. Li, Xinhong; L. Bao, Lili; P. Zhao, Pengwei

Journal: World Journal of Gastrointestinal Oncology

Year: 2024

Citations: 3

Effect of Staphylococcus aureus in pneumonia mouse model on promotion of mBD-3 expression through ERK1/2

Authors: Yongqing Ni, Xiaoduo Bi, Pengwei Zhao

Ligilactobacillus salivarius LZZAY01 accelerated autophagy and apoptosis in colon cancer cells and improved gut microbiota in CAC mice

Authors: Yang W, Li T, An S, Chen R, Zhao Y, Cui J, Zhang M, Lu J, Tian Y, Bao L, Zhao P

Journal: Microbiol Spectrum

Year: 2025

LPS Promoted HPMEC Autophagy by Suppression of the PI3K/Akt/mTOR through Inhibited TIMAP-Promoted Moesin Expression in Sepsis

Authors: Jili Wen, Pengwei Zhao, HuiJuan Ren, JunMin Wu

Journal: Journal of Biological Regulators and Homeostatic Agents

Year: 2023

Prof. Massimo Padalino | Medicinal Chemistry | Excellence in Innovation Award

Published on 21/02/2025 by Chemistry Awards

Prof. Massimo Padalino | Medicinal Chemistry | Excellence in Innovation Award

Prof. Massimo Padalino | Medicinal Chemistry | Professore associato at University of Bari, Italy

Dr. Massimo Antonio Padalino obtained his M.D. from the University of Padova, Italy, in 1995. He completed his residency in Cardiovascular Surgery at the University of Padova Medical School (1995-1999), where he served as Chief Resident (1999-2000). He pursued advanced surgical training through prestigious fellowships, including a Surgical Clinical Fellowship in Cardiovascular Surgery at the Mayo Clinic, USA (2001-2002), and specialized training in Pediatric Cardiovascular Surgery at Boston Children’s Hospital, Harvard Medical School (2002), and Mott Children’s Hospital, University of Michigan (2003-2004). He earned a Ph.D. in Cardiovascular Sciences from the University of Padova (2005-2008) and further specialized with a Master’s degree in Cardiovascular Pathology (2011) and Pediatric Cardiology (2014). Additionally, he completed a research fellowship at the Cardiac Registry, Harvard Medical School, and a visiting fellowship at Johns Hopkins Hospital (2015), solidifying his expertise in congenital and pediatric cardiac surgery.

Professional Profile :

Orcid

Scopus

Summary of Suitability for Award:

Dr. Massimo Antonio Padalino is an outstanding candidate for the “Excellence in Innovation Award” due to his pioneering contributions to pediatric and congenital cardiovascular surgery. His research has led to innovative surgical techniques for congenital heart disease, particularly in neonatal and single-ventricle repairs. His work on novel bioprosthetic materials, cardiac regeneration, and mechanical circulatory support (ECMO, VAD) has significantly improved patient outcomes. He has also played a key role in international registries (EUROFONTAN, EUROAAOCA) and multicenter studies, advancing global knowledge in congenital heart surgery. His collaboration with premier institutions like Harvard Medical School and Mayo Clinic further highlights his commitment to innovation. Dr. Padalino’s groundbreaking work in pediatric cardiac surgery, including innovative surgical strategies, regenerative medicine, and advanced circulatory support techniques, makes him highly suitable for the “Excellence in Innovation Award.” His contributions have transformed congenital heart disease treatment, making a lasting impact on the field.

🎓Education:

Dr. Massimo Antonio Padalino obtained his M.D. from the University of Padova in Italy. He completed his residency in Cardiovascular Surgery at the University of Padova Medical School (1995-1999), where he served as Chief Resident (1999-2000). He pursued advanced surgical training through prestigious fellowships, including a Surgical Clinical Fellowship in Cardiovascular Surgery at the Mayo Clinic, USA (2001-2002), and specialized training in Pediatric Cardiovascular Surgery at Boston Children’s Hospital, Harvard Medical School (2002), and Mott Children’s Hospital, University of Michigan (2003-2004). He earned a Ph.D. in Cardiovascular Sciences from the University of Padova (2005-2008) and further specialized with a Master’s degree in Cardiovascular Pathology (2011) and Pediatric Cardiology (2014). Additionally, he completed a research fellowship at the Cardiac Registry, Harvard Medical School, and a visiting fellowship at Johns Hopkins Hospital (2015), solidifying his expertise in congenital and pediatric cardiac surgery.

🏢Work Experience:

Dr. Massimo Antonio Padalino has over two decades of experience in pediatric and congenital cardiovascular surgery. Since December 2023, he has served as Pediatric and Congenital Cardiac Surgeon in Chief at UOC Cardiochirurgia, University of Bari, Italy. Previously, he was a senior Pediatric and Congenital Cardiovascular Surgeon at the University of Padova Medical School (2004-2023), where he independently performed approximately 150 complex congenital heart surgeries annually, spanning neonates to adults. His expertise includes neonatal heart surgery, single-ventricle palliation, heart transplantation, and mechanical circulatory support (ECMO and VAD). His clinical training includes tenures at leading institutions such as Mayo Clinic, Boston Children’s Hospital, and the University of Michigan. He has also been actively involved in postoperative intensive care, clinical research, and multicenter studies, significantly contributing to advancements in pediatric cardiac surgery. His leadership extends to mentoring and training the next generation of cardiac surgeons.

🏅Awards:

Dr. Massimo Antonio Padalino has received numerous accolades for his contributions to pediatric and congenital cardiovascular surgery. He is a Fellow of the European Society of Cardiology (FESC) and has been recognized for his expertise in congenital heart disease management. His work in innovative surgical strategies and regenerative medicine has earned him invitations to speak at leading international cardiology and cardiac surgery conferences. He has also received research grants for pioneering studies in cardiac regeneration, bioprosthetic materials, and surgical outcomes in congenital heart disease. His collaborations with renowned institutions, including Harvard Medical School and the Mayo Clinic, have strengthened his reputation as a leading figure in pediatric cardiac surgery. His research and clinical excellence are reflected in his numerous high-impact publications, which have significantly influenced advancements in congenital heart surgery and pediatric cardiology worldwide.

🔬Research Focus:

Dr. Massimo Antonio Padalino’s research focuses on congenital heart disease surgery, particularly early repair techniques and novel surgical strategies for single-ventricle physiology. He actively contributes to international registries, including the EUROFONTAN and EUROAAOCA, studying surgical outcomes in congenital heart defects. His work explores innovative approaches to preserving pulmonary valve function in Tetralogy of Fallot repair and alternative strategies for managing end-stage heart failure in children, including ECMO, VAD, and pulmonary artery banding. Additionally, he investigates heart transplantation in congenital heart disease, cardiac regeneration in infants with dilated cardiomyopathy, and bioprosthetic materials for cardiac tissue reconstruction. His research also addresses the neurological and pulmonary effects of cardiopulmonary bypass in pediatric patients, aiming to improve outcomes and long-term survival. Through clinical trials and multicenter studies, Dr. Padalino is dedicated to advancing pediatric cardiac surgery, refining surgical techniques, and enhancing postoperative care for children with complex congenital heart conditions.